Shares of Qingsong Health (02661) opened sharply higher, gaining more than 7%. At the time of writing, the stock is up 7.38% to HK$16, with a turnover of HK$5.7856 million.

The surge follows the company's announcement that its subsidiary, Beijing Qingsong Health Network Technology Co., Ltd., has entered into three health management service cooperation agreements with Yingda Taihe Life Insurance Co., Ltd. (Yingda Life). The agreements, signed on May 25, 2026, after friendly negotiations, are valid for one year. The company officially received the original copies of the legally executed agreements on June 5, 2026.

Scope of the Collaboration

The cooperation encompasses services including, but not limited to, medical treatment access and chronic disease management, health promotion and disease prevention, and rehabilitation care. The objective is to jointly establish a comprehensive, end-to-end health management service system.

Strategic Rationale and Benefits

The company's board of directors believes this collaboration aligns with the group's long-term development strategy. Through this partnership, the group will forge a deep cooperative relationship with Yingda Life in the health management service sector. This is expected to facilitate the large-scale deployment and application of the group's self-developed evidence-based medicine AI agent, "Zheng Yuanfang," within health management service scenarios.

Leveraging Yingda Life's nationwide customer base will provide a real-world, diverse environment to validate the AI evidence-based decision-making capabilities of "Zheng Yuanfang." This partnership is seen as a key step in accelerating the extension of the technology's capabilities from the professional medical practitioner side to the broader health management service domain.